Want to join the conversation?
Global pharmaceutical company $AGN said it has purchased Anterios, which develops next generation delivery system and botulinum toxin-based prescription products. $AGN paid an unfront $90MM and potential development and commercialization milestone payments related to NDS platform topical delivery technology.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.